临床试验

Safety and Clinical Performance of a Biological Matrix Used in Implant-based Breast Reconstruction

NCT：NCT05031962 · COMPLETED

NCT编号NCT05031962

状态COMPLETED

开始日期2021-10-04

完成时间2026-09-22

SponsorMeccellis Biotech (INDUSTRY)

First posted2021-09-02

Last updated2026-10-08

简要摘要

The general objective of the study is to confirm the medium/long-term safety and clinical performance of the CELLIS Breast membranes used in breast reconstruction and to identify emerging risks in comparison to clinical data related to other treatment modalities. The present study will be a prospective, multicentric, non-randomized and non-controlled trial involving 112 patients followed for 24 months. The study will be conducted in France in 7 investigational centres.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。